153 related articles for article (PubMed ID: 18548115)
1. Bullous pemphigoid autoantibodies preferentially recognize phosphoepitopes in collagen XVII.
Zimina EP; Hofmann SC; Fritsch A; Kern JS; Sitaru C; Bruckner-Tuderman L
J Invest Dermatol; 2008 Nov; 128(11):2736-2739. PubMed ID: 18548115
[No Abstract] [Full Text] [Related]
2. Pathogenesis of bullous pemphigoid.
Ujiie H; Nishie W; Shimizu H
Immunol Allergy Clin North Am; 2012 May; 32(2):207-15, v. PubMed ID: 22560134
[TBL] [Abstract][Full Text] [Related]
3. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis.
Roh JY; Yee C; Lazarova Z; Hall RP; Yancey KB
Br J Dermatol; 2000 Jul; 143(1):104-11. PubMed ID: 10886143
[TBL] [Abstract][Full Text] [Related]
4. Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.
Ujiie H; Sasaoka T; Izumi K; Nishie W; Shinkuma S; Natsuga K; Nakamura H; Shibaki A; Shimizu H
J Immunol; 2014 Nov; 193(9):4415-28. PubMed ID: 25261486
[TBL] [Abstract][Full Text] [Related]
5. Ectodomain shedding generates Neoepitopes on collagen XVII, the major autoantigen for bullous pemphigoid.
Nishie W; Lamer S; Schlosser A; Licarete E; Franzke CW; Hofmann SC; Jackow J; Sitaru C; Bruckner-Tuderman L
J Immunol; 2010 Oct; 185(8):4938-47. PubMed ID: 20861347
[TBL] [Abstract][Full Text] [Related]
6. High Expression of Collagen XVII Compensates for its Depletion Induced by Pemphigoid IgG in the Oral Mucosa.
Kamaguchi M; Iwata H; Ujiie H; Natsuga K; Nishie W; Kitagawa Y; Shimizu H
J Invest Dermatol; 2018 Aug; 138(8):1707-1715. PubMed ID: 29530535
[TBL] [Abstract][Full Text] [Related]
7. Complement-independent blistering mechanisms in bullous pemphigoid.
Iwata H; Ujiie H
Exp Dermatol; 2017 Dec; 26(12):1235-1239. PubMed ID: 28418613
[TBL] [Abstract][Full Text] [Related]
8. Context-Dependent Regulation of Collagen XVII Ectodomain Shedding in Skin.
Nishie W; Natsuga K; Iwata H; Izumi K; Ujiie H; Toyonaga E; Hata H; Nakamura H; Shimizu H
Am J Pathol; 2015 May; 185(5):1361-71. PubMed ID: 25773176
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against type XVII collagen C-terminal domain in a patient with bullous pemphigoid associated with psoriasis vulgaris.
Inokuma D; Kodama K; Natsuga K; Kasai M; Abe M; Nishie W; Abe R; Hashimoto T; Shimizu H
Br J Dermatol; 2009 Feb; 160(2):451-4. PubMed ID: 19077079
[No Abstract] [Full Text] [Related]
10. Autoantibodies of non-inflammatory bullous pemphigoid hardly deplete type XVII collagen of keratinocytes.
Imafuku K; Iwata H; Kamaguchi M; Izumi K; Natsuga K; Ujiie H; Nishie W; Shimizu H
Exp Dermatol; 2017 Dec; 26(12):1171-1174. PubMed ID: 28266727
[TBL] [Abstract][Full Text] [Related]
11. Bullous pemphigoid: a prototypical antibody-mediated organ-specific autoimmune disease.
Sitaru C
J Invest Dermatol; 2009 Apr; 129(4):822-4. PubMed ID: 19322161
[TBL] [Abstract][Full Text] [Related]
12. Plasmin plays a role in the in vitro generation of the linear IgA dermatosis antigen LADB97.
Hofmann SC; Voith U; Schönau V; Sorokin L; Bruckner-Tuderman L; Franzke CW
J Invest Dermatol; 2009 Jul; 129(7):1730-9. PubMed ID: 19158842
[TBL] [Abstract][Full Text] [Related]
13. Epitope-spreading phenomena in dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid.
García-Díez I; España A; Iranzo P
Br J Dermatol; 2019 May; 180(5):1267-1268. PubMed ID: 30675718
[No Abstract] [Full Text] [Related]
14. Bullous pemphigoid induced by pembrolizumab in a patient with advanced melanoma expressing collagen XVII.
Wada N; Uchi H; Furue M
J Dermatol; 2017 Oct; 44(10):e240-e241. PubMed ID: 28677843
[No Abstract] [Full Text] [Related]
15. Autoantibodies from patients with localized and generalized bullous pemphigoid immunoprecipitate the same 230-kd keratinocyte antigen.
Domloge-Hultsch N; Utecht L; James W; Yancey KB
Arch Dermatol; 1990 Oct; 126(10):1337-41. PubMed ID: 2221940
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of bullous pemphigoid.
Ujiie H; Nishie W; Shimizu H
Dermatol Clin; 2011 Jul; 29(3):439-46, ix. PubMed ID: 21605809
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid.
Izumi K; Nishie W; Mai Y; Wada M; Natsuga K; Ujiie H; Iwata H; Yamagami J; Shimizu H
J Invest Dermatol; 2016 Nov; 136(11):2201-2210. PubMed ID: 27424319
[TBL] [Abstract][Full Text] [Related]
18. [Auto-immune bullous diseases autoantibodies (pemphigus, bullous pemphigoid): what the dermatologist must know].
Ingen-Housz-Oro S; Hüe S; Grootenboer-Mignot S; André C
Ann Dermatol Venereol; 2013; 140(8-9):563-70. PubMed ID: 24034645
[No Abstract] [Full Text] [Related]
19. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.
Sitaru C; Dähnrich C; Probst C; Komorowski L; Blöcker I; Schmidt E; Schlumberger W; Rose C; Stöcker W; Zillikens D
Exp Dermatol; 2007 Sep; 16(9):770-7. PubMed ID: 17697150
[TBL] [Abstract][Full Text] [Related]
20. Exploring mechanisms of IgE-mediated autoimmunity through the lens of bullous pemphigoid.
Messingham KN; Randall G; Fairley J
G Ital Dermatol Venereol; 2016 Apr; 151(2):186-97. PubMed ID: 26959553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
